CTSO News and Press, CytoSorbents Corporation

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights PR Newswire PRINCETON, N.J. , March 5, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the inten...

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update PR Newswire Fourth quarter and Full-Year 2025 revenue are expected to be approximately   $9.2 million and $37.0 million , respectively, with expected Q4 gross margins ...

2025-12-15 15:59:34 ET Cytosorbents Corporation (CTSO) Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's Regulatory Path December 15, 2025 11:00 AM EST... Read the full article on Seeking Alpha For further details see: Cytosorbents Corporation (CTSO) Discu...

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 PR Newswire PRINCETON, N.J. , Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the i...

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive car...

2025-11-13 19:22:23 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cytosorbents Historical earnings data for Cytosorbents Financial information for Cytosorbents Read th...

2025-11-13 19:21:34 ET Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript

2025-11-13 16:11:34 ET More on Cytosorbents Seeking Alpha’s Quant Rating on Cytosorbents Historical earnings data for Cytosorbents Financial information for Cytosorbents Read the full article on Seeking Alpha For further details see: Cytoso...

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire Third quarter 2025 revenue of $9.5 million , up 10% year-over-year Amended credit agreement with Avenue Capital Group which strengthens our balance sheet with an additional $2.5...

2025-11-13 10:00:00 ET Read the full article on Seeking Alpha For further details see: Here are the major earnings after the close Thursday